A benzoheterocyclic derivative of the following formula [1]:
and pharmaceutically acceptable salts thereof, which show excellent anti-vasopressin activity, vasopressin agonistic activity and oxytocin antagonistic activity, and are useful as a vasopressin antagonist, vasopressin agonist or oxytocin antagonist.
TETRAHYDROQUINOLINE DERIVATIVES AS ANTITHROMBOTIC AGENTS
申请人:BRISTOL-MYERS SQUIBB COMPANY
公开号:EP1425015A2
公开(公告)日:2004-06-09
EP1425015A4
申请人:——
公开号:EP1425015A4
公开(公告)日:2004-12-15
[EN] TETRAHYDROQUINOLINE DERIVATIVES AS ANTITHROMBOTIC AGENTS<br/>[FR] DERIVES DE TETRAHYDROQUINOLINE UTILISES COMME AGENTS ANTITHROMBOTIQUES
申请人:BRISTOL MYERS SQUIBB CO
公开号:WO2003015715A2
公开(公告)日:2003-02-27
This invention relates generally to tetracyclic tetrahydroquinoline compounds, and analogues thereof, and pharmaceutically acceptable salt forms thereof, which are selective inhibitors of serine protease enzymes, especially factor VIIa; pharmaceutical compositions containing the same; and methods of using the same as anticoagulant agents for modulation of the coagulation cascade.
Towards New Iron(III) Chelators: Synthesis and Complexing Ability of a Water-Soluble Tripodal Ligand Based on 2,2′-Dihydroxybiphenyl Subunits